Sign-up to Receive
Our Latest Insights

CYBO
VanEck Bionic Engineering UCITS ETF

Fund Description

As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck’s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.

  • Invest in companies at the forefront of improving quality of life for the world’s ageing population
  • Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments
  • Access companies earning at least half their revenues from bionic engineering-related industries
  • Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco


Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KID and in the sales prospectus. Outperformance not guaranteed.



Underlying Index

MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)

Fund Details
 

  • Fund Ticker

    CYBO
  • Management Company

    VanEck Asset Management B.V.
  • Custodian

    State Street Custodial Services (Ireland) Limited
  • Domicile

    Ireland
  • UCITS Compliant

    Yes
  • Index Ticker

    MVBIONTR
  • Index Provider

    MarketVector Indexes
  • Rebalance Frequency

    Quarterly
1The "Net Asset Value" (NAV) of all ETFs is determined at the close of each business day, and represents the value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell ETF shares at NAV.

2The date the fund was launched prior to quotation on the stock exchange.

 
as of 31 Jan 2023

  • NAV1

    20.57
  • Shares Outstanding

    260,000
  • Number of Holdings

    25
  • Base Currency

    USD
  • Net Assets

    $5.3M
  • Product Structure

    Physical (Full Replication)
  • Income Treatment

    Reinvestment
  • Distribution Frequency

    None
  • Total Expense Ratio

    0.55%
  • SFDR Classification

    Article 9
  • Fact Sheet
  • Fund Holiday Calendar

Trading Information as of 31 Jan 2023

Deutsche
Börse
EUR
Exchange Ticker CIBO
ISIN IE0005TF96I9
SEDOL BMTPPJ3
Bloomberg CIBO GY
Reuters (RIC) CIB0.DE
Valor --
Bloomberg iNAV CYBOUSIV
Reuters iNAV CYBOEURINAV=IHSM
WKN A3DT2R
Trading Currency EUR
Last Traded Price
Day's Move
Volume
30 Day Volume --
VWAP Volume

NAVs as of 31 Jan 2023

Base
Currency
NAV Daily
Change
NAV
YTD
Change
NAV
NAV Price
History
Total
Expense
Ratio
CYBO USD $20.57 $0.09 / +0.46% +3.95%
0.55

Performance History* (%)

  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVBIONTR (Index) 0.36 12.45 -22.10 -22.10 -- -- -- -1.85
  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVBIONTR (Index) 0.36 12.45 -22.10 -22.10 -- -- -- -1.85
  2018 2019 2020 2021 2022
MVBIONTR (Index) -- -- -- -- -22.10

Market Makers

Top 10 Holdings (%) as of 31 Dec 2022 View All Holdings »

Total Holdings: 25
Swipe<br>to view <br> full data
Holding Name
Ticker
Shares Market Value
(USD)
% of Net
Assets
EDWARDS LIFESCIENCES CORP EW US 7,075 527,866 10.26
MEDTRONIC PLC MDT US 6,676 518,859 10.09
STRYKER CORP SYK US 2,121 518,563 10.08
DEXCOM INC DXCM US 4,355 493,160 9.59
ZIMMER BIOMET HOLDINGS INC ZBH US 3,232 412,080 8.01
SONOVA HOLDING AG SOON SW 1,127 267,133 5.19
INSULET CORP PODD US 756 222,559 4.33
STRAUMANN HOLDING AG STMN SW 1,926 219,829 4.27
INSPIRE MEDICAL SYSTEMS INC INSP US 746 187,902 3.65
SMITH & NEPHEW PLC SNN US 6,985 187,827 3.65
Top 10 Total (%) 69.12
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 31 Dec 2022

  • Country

    % of Net Assets
  • United States

    75.63
  • Switzerland

    9.47
  • United Kingdom

    3.65
  • Australia

    3.02
  • China

    2.73
  • Italy

    2.29
  • South Korea

    1.86
  • Denmark

    1.19
  • Other/Cash

    0.14

Sector Weightings (%) as of 31 Dec 2022

  • Sector

    % of Net Assets
  • Health Care

    99.9
  • Other/Cash

    0.1

Discover more ETFs

More ETFs